SCHEMBL3597093

SCHEMBL3597093

O=C(Cn1cnc2cc(Cl)ccc21)NCCNCC1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.47
CTSD P07339 1/20 0.45
KCNH2 Q12809 1/20 0.45
BACE2 Q9Y5Z0 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
HPGD P15428 2/20 0.41
PRPS1 P60891 1/20 0.41
NAMPT P43490 1/20 0.40
TRPA1 O75762 3/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.40
RECQL P46063 1/20 0.40
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3602189 0.88 HPGD (0.43) MEN1KMT2AHPGDNAMPTTRPA1
SCHEMBL3605823 0.88 HTT (0.42) MEN1KMT2ATSHRHTTHPGD
SCHEMBL3606208 0.85 TP53 (0.44) MEN1KMT2ATSHRHTTHPGD
SCHEMBL3599702 0.84 GRIN2B (0.41) MEN1KMT2AHPGDNAMPTTRPA1
SCHEMBL5345354 0.82 TRPA1 (0.44) MEN1KMT2AHTTHPGDTRPA1
SCHEMBL3597098 0.81 KMT2A (0.42) BACE1CTSDKCNH2BACE2MEN1
SCHEMBL3608393 0.80 PRPS1 (0.41) MEN1KMT2ATSHRHTTHPGD
SCHEMBL5367271 0.79 MTNR1A (0.53) KMT2ATSHRHTTHPGDALDH1A1
SCHEMBL3597269 0.77 ENPP2 (0.45) MEN1KMT2ATSHRHTTHPGD
SCHEMBL3605623 0.77 TRPA1 (0.43) MEN1KMT2AHPGDTRPA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 BACE1 3253/4885CTSD 1571/4885KCNH2 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.